menu
    • menu
    [{"orgOrder":0,"company":"Simris Biologics","sponsor":"Nuvisan GmbH","pharmaFlowCategory":"DU","therapeuticArea":"Oncology","country":"GERMANY","productType":"Antibody-drug Conjugate","year":"2025","type":"Inapplicable","leadProduct":"SIMRIS-121","moa":"Undisclosed","graph1":"Oncology","graph2":"Preclinical","graph3":"Simris Biologics","amount2":0,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Simris Biologics \/ Nuvisan GmbH","highestDevelopmentStatusID":"4","companyTruncated":"Simris Biologics \/ Nuvisan GmbH"}]

    Find Clinical Drug Pipeline Developments & Deals by Simris Biologics

    Menu

    Simris Biologics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Simris Biologics

                            Germany arrow
                            COMPAMED
                            Not Confirmed

                            Simris Biologics

                            Germany arrow
                            COMPAMED
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : SIMRIS-121

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Nuvisan GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Simris Group AB Reports Positive Results from ADC Study with Nuvisan

                            Details : SIMRIS-121, an antibody-drug conjugate, shows promising results in treating cancer, targeting an undisclosed biomarker.

                            Product Name : Undisclosed

                            Product Type : Antibody-drug Conjugate

                            Upfront Cash : Inapplicable

                            November 06, 2025

                            Lead Product(s) : SIMRIS-121

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Nuvisan GmbH

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth